Filtros de búsqueda

Lista de obras de Jolanda de Vries

A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets.

artículo científico

A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies

artículo científico publicado en 2022

A large-scale 19F MRI-based cell migration assay to optimize cell therapy

artículo científico publicado en 2012

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients.

artículo científico publicado en 2010

A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery

artículo científico publicado en 2021

Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma.

artículo científico publicado en 2016

Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients.

artículo científico publicado en 2016

An Altered gp100 Peptide Ligand with Decreased Binding by TCR and CD8α Dissects T Cell Cytotoxicity from Production of Cytokines and Activation of NFAT.

artículo científico publicado en 2013

Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial

scientific article published on 24 January 2020

Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination.

artículo científico publicado en 2011

Cell tracking using (19)F magnetic resonance imaging: technical aspects and challenges towards clinical applications.

artículo científico publicado en 2014

Cell tracking using multimodal imaging.

artículo científico publicado en 2013

Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis

scientific article published on 01 February 2016

DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells

scientific article published on 17 March 2011

Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.

artículo científico publicado en 2016

Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination.

artículo científico publicado en 2014

Dendritic cell vaccination in melanoma patients: From promising results to future perspectives

artículo científico publicado en 2016

Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging.

artículo científico publicado en 2011

Early predictive value of multifunctional skin-infiltrating lymphocytes in anticancer immunotherapy

artículo científico

Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment

artículo científico publicado en 2017

Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.

artículo científico publicado en 2015

Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.

artículo científico publicado en 2016

Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination.

artículo científico publicado en 2015

Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents

artículo científico publicado en 2010

Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis

artículo científico publicado en 2012

Harnessing human plasmacytoid dendritic cells as professional APCs.

artículo científico

Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy

article

Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity.

artículo científico publicado en 2016

Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.

artículo científico publicado en 2012

Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.

artículo científico publicado en 2012

Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigue

artículo científico publicado en 2015

Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters ⬇️

artículo científico publicado el 21 de abril de 2012

IL-4 and IL-13 alter plasmacytoid dendritic cell responsiveness to CpG DNA and herpes simplex virus-1.

artículo científico publicado en 2010

Immune infiltrates impact on the prediction of prognosis and response to immunotherapy of melanoma patients

Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients.

artículo científico publicado en 2016

Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens.

artículo científico

Importance of helper T-cell activation in dendritic cell-based anticancer immunotherapy.

artículo científico publicado en 2013

Improving cancer immunotherapy by targeting the STATe of MDSCs

artículo científico publicado en 2016

In vivo imaging of therapy-induced anti-cancer immune responses in humans ⬇️

artículo científico publicado el 5 de octubre de 2012

In vivo tracking techniques for cellular regeneration, replacement, and redirection.

artículo científico publicado en 2012

Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients

artículo científico publicado en 2015

Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination

artículo científico publicado en 2016

Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients

artículo científico publicado en 2014

Long-lasting multifunctional CD8(+) T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination

artículo científico publicado en 2015

Molecular pathways: the immunogenic effects of platinum-based chemotherapeutics.

artículo científico publicado en 2014

Multispectral imaging for highly accurate analysis of tumour-infiltrating lymphocytes in primary melanoma

artículo científico publicado en 2016

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

article

Naturally circulating dendritic cells to vaccinate cancer patients.

artículo científico publicado en 2013

Opportunities for immunotherapy in microsatellite instable colorectal cancer

artículo científico publicado en 2016

PLGA-encapsulated perfluorocarbon nanoparticles for simultaneous visualization of distinct cell populations by 19F MRI.

artículo científico publicado en 2015

Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets.

artículo científico

Potential applications for plasmacytoid dendritic cells in cancer immunotherapy.

artículo científico publicado en 2012

Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition.

artículo científico publicado en 2016

Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.

artículo científico publicado en 2016

Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses.

artículo científico publicado en 2011

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets

artículo científico publicado en 2015

Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function

artículo científico publicado en 2016

Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect

artículo científico publicado en 2015

Reducing cell number improves the homing of dendritic cells to lymph nodes upon intradermal vaccination

artículo científico publicado en 2013

Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment

artículo científico publicado en 2014

Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients

artículo científico publicado en 2011

STAT Family Protein Expression and Phosphorylation State during moDC Development Is Altered by Platinum-Based Chemotherapeutics

scientific article published on 11 June 2019

STATing the importance of immune modulation by platinum chemotherapeutics ⬇️

artículo científico publicado el 1 de marzo de 2012

Scientific contributions toward successful cancer immunotherapy in The Netherlands.

artículo científico

Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell-Based Vaccination in Metastatic Melanoma

artículo científico publicado en 2012

Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients.

artículo científico publicado en 2010

T-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell Vaccines

artículo científico publicado en 2016

Targeted delivery of CpG ODN to CD32 on human and monkey plasmacytoid dendritic cells augments IFNα secretion.

artículo científico publicado en 2012

Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion

artículo científico publicado en 2013

Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells

scientific article published on 04 February 2013

The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells

scientific article published on 10 January 2012

The lymphoid chemokine CCL21 triggers LFA-1 adhesive properties on human dendritic cells

artículo científico publicado en 2010

The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture

scientific article published on 02 June 2020

Tumoricidal activity of human dendritic cells.

artículo científico publicado en 2013

Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists

artículo científico publicado en 2015

Unraveling the human dendritic cell phagosome proteome by organellar enrichment ranking

artículo científico publicado en 2011

Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients

article

Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used

article

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda